(Q45754303)

15 December 2017

title

Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy (English)

1 reference

15 December 2017

11

Gen Sobue

1 reference

15 December 2017

Atsushi Hashizume

1

1 reference

15 December 2017

Masahisa Katsuno

2

1 reference

15 December 2017

Haruhiko Banno

3

1 reference

15 December 2017

Keisuke Suzuki

4

1 reference

15 December 2017

Noriaki Suga

5

1 reference

15 December 2017

Tomoo Mano

6

1 reference

15 December 2017

Naoki Atsuta

7

1 reference

15 December 2017

Hiroaki Oe

8

1 reference

15 December 2017

Hirohisa Watanabe

9

1 reference

15 December 2017

Fumiaki Tanaka

10

1 reference

15 December 2017

language of work or name

English

0 references

publication date

6 July 2012

1 reference

15 December 2017

published in

Brain

1 reference

15 December 2017

volume

135

1 reference

15 December 2017

issue

Pt 9

1 reference

15 December 2017

page(s)

2838-2848

1 reference

15 December 2017

CAG repeat number correlates with the rate of brainstem and cerebellar atrophy in Machado-Joseph disease

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Onset and progression in inherited ALS determined by motor neurons and microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Treatment of vascular risk factors is associated with slower decline in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Apoptosis and caspases in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

The propagation of prion-like protein inclusions in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Alzheimer's disease: Moving towards a vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Guidelines for the use and performance of quantitative outcome measures in ALS clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Intra- and interrater variation in the evaluation of videofluorographic swallowing studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Random-effects models for longitudinal data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Polyglutamines placed into context

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Trinucleotide Repeat Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

"Disease-modification" trials in Parkinson disease: target populations, endpoints and study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

CAG repeats determine brain atrophy in spinocerebellar ataxia 17: a VBM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Clinical features of spinal and bulbar muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Mixed models and unbalanced data: wherefrom, whereat and whereto?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

X-linked bulbospinal neuronopathy: Kennedy disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Utility of cystatin C to monitor renal function in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWS170

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWS170

1 reference

15 December 2017

1 reference

15 December 2017